Table 2.
Mean peak height (PH) of significantly different lipids in X-deletion sample injections (n = 3) compared to control sample injections (n = 3) and their ratio in negative mode (ID methods: ID methods: 1 = More than one MS/MS fragment m/z match to in silico database from data dependent (top 5), 2 = all-ion fragmentation MS/MS fragment m/z match).
Lipid Name | m/z | Ion/Adduct | ID methods | Mass Accuracy (ppm) | Average X-deletion PH (n = 3) | X-deletion RSD (%) | Average Control PH (n = 3) | Control RSD (%) | X-deletion/ Control |
---|---|---|---|---|---|---|---|---|---|
PG(20:3_20:3) | 821.5358 | [M−H]− | 1,2 | 2.5 | 2.76E+06 | 1.79 | 9.64E+04 | 5 | 28.7 |
PG(18:1_20:4) | 795.5199 | [M−H]− | 1,2 | 2.3 | 9.93E+06 | 0.61 | 6.08E+05 | 9.4 | 16.3 |
Plasmanyl-PC(O-16:1/20:4) | 810.5674 | [M+HCO2]− | 1 | 2.4 | 1.28E+07 | 0.9 | 8.59E+05 | 1.62 | 15 |
PG(18:2_20:3) | 795.5200 | [M−H]− | 1,2 | 3.1 | 3.72E+05 | 1.94 | 2.90E+04 | 14.78 | 12.8 |
Plasmenyl-PC(P-18:1/20:4) | 836.5830 | [M+HCO2]− | 1 | 2.3 | 8.14E+06 | 0.63 | 6.83E+05 | 3.98 | 11.9 |
Plasmanyl-PC(O-18:1/20:4) | 838.5981 | [M+HCO2]− | 1 | 1.6 | 2.19E+06 | 2.67 | 1.85E+05 | 6.41 | 11.9 |
Plasmanyl-PC(O-16:1/22:4) | 838.5975 | [M+HCO2]− | 1 | 0.1 | 3.72E+06 | 2.96 | 4.13E+05 | 4.5 | 9.02 |
PG(20:4_20:4) | 817.5049 | [M−H]− | 2 | 3 | 5.31E+05 | 3.85 | 6.31E+04 | 1.28 | 8.41 |
Plasmanyl-PC(O-16:1/20:3) | 812.5826 | [M+HCO2]− | 1 | 1.9 | 9.60E+05 | 2.24 | 1.21E+05 | 7.05 | 7.95 |
Plasmenyl-PC(P-18:1/22:4) | 864.6134 | [M+HCO2]− | 1 | 1.2 | 1.97E+06 | 3.46 | 2.53E+05 | 21.71 | 7.78 |